R. Eberhardt (Heidelberg, Germany), A. Fisseler-Eckhoff (Wiesbaden, Germany)
Diagnostic accuracy of endobronchial ultrasonography using a guide sheath for peripheral lung cancer with ground-glass opacity
M. Okamoto, N. Kurimoto, M. Mineshita, T. Miyazawa (Kawasaki, Japan)
|   |
Pathologic analysis of autofluorescence bronchoscopy between heavy smokers with or not airway obstruction
E. Lee, S. Kim, M. Beom (Suncheonsi, Republic Of Korea)
| |
Prevalence of preinvasive bronchial lesions in patients with lung cancer
A. Mohamed, A. AbdelAzim, K. Shibuya (Assuit, Egypt; Chiba, Japan)
| |
Bronchoscopic semantics and diagnosis of lung cancer
V. Sacramento, J. Dionísio, J. Duro da Costa (Barreiro, Lisboa, Portugal)
| |
Can ultraviolet (UV) bronchoscopy detect lung cancers? A prototype study
J. M. Vergnon, F. Di Palma, R. Barker, Y. Thibout, A. Clemenson, J. M. Bacchus (Saint Etienne, Saint Heand, France)
| |
Diagnostic yield, safety and utilisation of EBUS-TBNA under conscious sedation
U. Maqsood, S. Selvaraj, M. Healy, K. Malcki, M. Chaudri (Dudley, United Kingdom)
| |
Patient and procedure determinants of EBUS-TBNA accuracy in mediastinal staging of lung cancer
E. Monso, L. Seto, G. Bermudo, C. Monton, R. Cordovilla, J. Sanz, B. Cosio, A. Fernandez-Villar, R. Garcia-Lujan, E. Cases (Sabadell, Madrid, Vigo, Valencia, Salamanca, Badalona, Palma, Spain)
| |
Visible tumour on bronchoscopy: Do we need cytology?
M. Naeem, R. Reddy (Kettering, United Kingdom)
| |
Post-bronchoscopy sputum in the current bronchoscopy technique dose not improve the diagnostic yield in thoracic malignancies
A. Kitamura, Y. Yamano, G. Ishikawa, Y. Tomishima, T. Jinta, N. Nishimura, N. Chohnabayashi (Tokyo, Japan)
| |
EBUS/EUS – Cell smears or cytoblocks?
J. Wegrzyn, J. Buczkowski, J. Pankowski, A. Szlubowski, M. Sroda, M. Jakubiak, A. Obrochta (Zakopane, Lublin, Warszawa, Poland)
| |
Usefulness of rapid on-site microscopic evaluation (ROME) of core biopsy specimen of EBUS-TBNA
M. H. Jung, C. H. Oak, T. W. Jang, B. K. Cheon (Busan, Republic Of Korea)
| |
The level of bronchoalveolar lavage fluid prostaglandine E2; Is it diagnostic of bronchogenic carcinoma?
A. Shawky, G. Elkhouly, I. Ibrahim, M. Hantera, S. Mohamed (Tanta, Egypt)
| |
Ideal volume sampling in the diagnosis of malignant pleural effusions. Just how much is really enough?
V. Anastasakos, D. Mpisirtzoglou, A. Zetos, C. Marketos, S. Mpampoukos, G. Politis (Athens, Greece)
| |
Conventional cytology vs liquid based cytology in preparation of bronchial wash, does the later have potential advantages?
B. Kathiresan, S. Iles, L. Glinski (Plymouth, Truro, United Kingdom)
| |
EGFR, KRAS, HER2, BRAF and PI3KCA mutation status in metastatic cancer patients: Thoracic cytological specimens obtained in routine clinical practice
T. Vandemoortele, I. Nanni-Metellus, E. Kaspi, V. Secq, S. Laroumagne, P. Roll, E. Roca, H. Dutau, A. Robaglia, P. Astoul (Marseille, France)
| |
Cytological samples for the study of EGFR, KRAS and ALK mutations in non-small cell lung cancer
C. Becker, E. Carcereny Costa, F. Andreo Garcia, E. Castellá, M. Lletjós Sanuy, T. Morán, E. Mijangos Basterra, J. Sanz Santos, C. Centeno Clemente, J. Ruiz Manzano (Badalona, Spain)
| |
The “COLD-PCR-approach” for early and cost-effective detection of tyrosine kinase inhibitor resistance
F. Mairinger, C. Vollbrecht, A. Streubel, A. Roth, R. Walter, T. Mairinger (Essen, Cologne, Berlin, Germany)
| |
The art of detecting EML4-ALK gene rearrangements in NSCLC patients – Immediate implications for patient care
M. Pekar, M. Ilouze, V. Miller, D. Lipson, S. Ali, J. Bar, A. Onn, D. Shlomi, M. Elimelech, L. Soussan-Gutman, M. Wynes, F. R. Hirsch, N. Peled (Ramat-Gan, Petach Tikva, Israel; Cambridge, Aurora, United States Of America)
| |